Last reviewed · How we verify
NCT03445312: Salient
Safety and Effectiveness of a Laboratory Intervention to Effectively NOT Treat Asymptomatic Bacteriuria
trial testing not processing urine cultures in Asymptomatic Bacteriuria in 1,394 participants. Completed in 15 November 2019.
15 May 2019
Quick facts
| Lead sponsor | Mount Sinai Hospital, Canada |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,394 |
| Start date | 31 August 2017 |
| Primary completion | 15 May 2019 |
| Estimated completion | 15 November 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- not processing urine cultures
Conditions studied
- Asymptomatic Bacteriuria — all drugs for Asymptomatic Bacteriuria →
- Urinary Tract Infections — all drugs for Urinary Tract Infections →
Sponsor
Mount Sinai Hospital, Canada
Who can join
Eligibility, any sex, with Asymptomatic Bacteriuria or Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational cohort study of 1000 consecutive patients on medical and surgical wards at the Mount Sinai Hospital in Toronto who have a mid-stream urine culture ordered. When these cultures are ordered or received in the laboratory, a message is posted that the specimen will not be processed in the laboratory unless a call is received to say that the patient has local urinary symptoms. The goal is to establish whether not processing mid-stream urine cultures is safe.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03445312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asymptomatic Bacteriuria
Currently open trials in the same condition.
- NCT05554081 — Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB · NA · active not recruiting
Other Mount Sinai Hospital, Canada trials
Trials by the same sponsor.
- NCT07272460 — Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial · NA · recruiting
- NCT07046572 — Methoxyflurane for IUD Insertion and Endometrial Biopsy · NA · recruiting
- NCT06504277 — Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain · NA · recruiting
- NCT06546254 — 1% Lidocaine Paracervical Block for Endometrial Biopsy · NA · completed
- NCT06733701 — The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03445312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mount Sinai Hospital, Canada
- Last refreshed: 1 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03445312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing